A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
Public ClinicalTrials.gov record NCT02326454. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomised, Double-blind, Placebo Controlled, Study of MR901 in Patients With Moderate to Severe Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study investigates the safety and efficacy of a photosensitive drug (talaporfin sodium) activated by an intraurethrally placed drug-activating device. MR901 is a code used to identify the combination of talaporfin sodium and the drug-activating device. Two different light doses will be tested against placebo groups in this 4-arm study.
Study identification
- NCT ID
- NCT02326454
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 225 participants
Conditions and interventions
Conditions
Interventions
- talaporfin sodium Drug
- Saline Drug
- Drug Activator 100 J/cm Device
- Drug Activator 200 J/cm Device
Drug · Device
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2014 (Type not available)
- Primary completion
- Mar 29, 2017 (Actual)
- Completion
- Mar 29, 2017 (Actual)
- Last update posted
- Aug 8, 2018
2014 – 2017
United States locations
- U.S. sites
- 41
- U.S. states
- 22
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Anniston | Alabama | 36207 | — |
| Not listed | Huntsville | Alabama | 35801 | — |
| Not listed | Anchorage | Alaska | 99503 | — |
| Not listed | Laguna Hills | California | 92653 | — |
| Not listed | Los Angeles | California | 90017 | — |
| Not listed | Murrieta | California | 92562 | — |
| Not listed | San Diego | California | 92120 | — |
| Not listed | Tarzana | California | 91356 | — |
| Not listed | Denver | Colorado | 80220 | — |
| Not listed | Aventura | Florida | 33180 | — |
| Not listed | Bradenton | Florida | 34205 | — |
| Not listed | Coral Gables | Florida | 33146 | — |
| Not listed | Pompano Beach | Florida | 33060 | — |
| Not listed | St. Petersburg | Florida | 33710 | — |
| Not listed | Tampa | Florida | 33607 | — |
| Not listed | Bloomington | Indiana | 47403 | — |
| Not listed | Greenwood | Indiana | 46143 | — |
| Not listed | New Orleans | Louisiana | 70006 | — |
| Not listed | New Orleans | Louisiana | 70115 | — |
| Not listed | Greenbelt | Maryland | 20770 | — |
| Not listed | Towson | Maryland | 21204 | — |
| Not listed | Chestnut Hill | Massachusetts | 02467 | — |
| Not listed | Las Vegas | Nevada | 89144 | — |
| Not listed | Edison | New Jersey | 08837 | — |
| Not listed | Albuquerque | New Mexico | 87109 | — |
| Not listed | Garden City | New York | 11530 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | Newburgh | New York | 12601 | — |
| Not listed | Poughkeepsie | New York | 12601 | — |
| Not listed | Concord | North Carolina | 28025 | — |
| Not listed | Cincinnati | Ohio | 45212 | — |
| Not listed | Middleburg Heights | Ohio | 44130 | — |
| Not listed | Springfield | Oregon | 97477 | — |
| Not listed | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Not listed | Bryn Mawr | Pennsylvania | 19010 | — |
| Not listed | Myrtle Beach | South Carolina | 29572 | — |
| Not listed | Knoxville | Tennessee | 37923 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Houston | Texas | 77094 | — |
| Not listed | Salt Lake City | Utah | 84124 | — |
| Not listed | Mountlake Terrace | Washington | 98043 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02326454, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 8, 2018 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02326454 live on ClinicalTrials.gov.